RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development ...Middle East

PR Newswire - News
RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development
BEIJING, Nov. 19, 2024 /PRNewswire/ -- With the support of the RiDYMO® platform, we are able to comprehensively explore various potential targets in drug development, including protein-protein interactions, kinases, GPCRs, ion channels, and transcription factors. Polo-like kinase 1 (PLK1)...

Read More Details
Finally We wish PressBee provided you with enough information of ( RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development )

Apple Storegoogle play

Also on site :